The Canadian Morphea Registry: Design, Baseline Characteristics, and Age-Related Differences in a National Multicenter Cohort
Journal of Cutaneous Medicine and Surgery · 01.11.2026
DOI: 10.1177/12034754261490572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Medicine and Surgery, online erschienen am 01.11.2026. Verfasst von Xin Xin Yu und 33 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Canada’s Drug Agency, Canadian Dermatology Foundation, SkIN Canada.
Abstract (Originalsprache)
Background
Morphea is a rare immune-mediated fibrosing skin disorder with heterogeneous clinical manifestations across the lifespan. Existing large cohorts have predominantly originated from the United States and Europe, while national Canadian data spanning pediatric and adult disease are lacking.
Objective
To characterize morphea across the lifespan in a national Canadian cohort, with particular emphasis on age-related differences in clinical phenotype, diagnostic pathways, disease burden, and treatment patterns.
Methods
The Canadian Morphea Registry (C-MORE) is an ongoing prospective, multicenter observational registry of pediatric and adult patients with morphea and eosinophilic fasciitis. Baseline demographic, clinical, treatment, and patient-reported outcome data accrued from June 2021 through August 2025 were analyzed and compared by age group and against established international registries.
Results
Among 213 patients enrolled across 9 academic centers, 68.5% were adults; 31.5% were children. Linear morphea predominated in children (49.2%) and generalized morphea in adults (31.3%). The mean diagnostic delay was 1.9 years, and 27.2% reported prior misdiagnosis, most commonly eczema. Adults had higher baseline disease activity, whereas children carried greater cumulative damage, including among those classified as inactive. Systemic therapy was more common in children (61.0%) than adults (39.1%); methotrexate was most frequently prescribed.
Conclusion
C-MORE provides the first national Canadian characterization of pediatric and adult morphea within a publicly funded healthcare system. Marked age-related differences in phenotype, disease activity, accumulated damage, and treatment were observed, while diagnostic delay and frequent prior misdiagnosis remained important across age groups. Longitudinal follow-up will determine how these differences influence disease trajectories and treatment outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
- Faculty of Medicine, Université de Montreal, Montreal, QC, Canada.
- Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
- College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
- Division of Dermatology, Department of Medicine, McGill University, Health Centre, Montreal, QC, Canada.
- Division of Dermatology, Department of Medicine, Université de Sherbrooke, Sherbrooke, QC, Canada.
ORCID-Profile: Xin Xin Yu, Maxine Joly-Chevrier, Emma Rispler, Catherine Keying Zhu, Stephanie Ghazal, Alexandra Mereniuk, Elena Pope, Elena Netchiporouk
Förderung
- Canada’s Drug Agency
- Canadian Dermatology Foundation
- SkIN Canada
- Institut de recherche en dermatologie de Montréal
Zitieren
APA
Yu, X. X., Muha, J., Li, M. C., Bobica, A. C., Joly-Chevrier, M., Rispler, E., Yilmaz, O., Zhu, C. K., Ghazal, S., Veilleux, M., Bruns, A., Bissonnette, L., Jariwala, M., Batthish, M., Muntyanu, A., Mereniuk, A., Proulx-Gauthier, J. P., Dionne, M. C., Pinard, J., …, & Canadian Morphea Registry (C-MORE) Investigators (2026). The Canadian Morphea Registry: Design, Baseline Characteristics, and Age-Related Differences in a National Multicenter Cohort. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754261490572
Vancouver
Yu XX, Muha J, Li MC, Bobica AC, Joly-Chevrier M, Rispler E, et al. The Canadian Morphea Registry: Design, Baseline Characteristics, and Age-Related Differences in a National Multicenter Cohort. Journal of Cutaneous Medicine and Surgery. 2026. doi:10.1177/12034754261490572
BibTeX
@article{Yu2026,
author = {Yu, Xin Xin and Muha, Jessica and Li, Meng Cathy and Bobica, Alexandra Carla and Joly-Chevrier, Maxine and Rispler, Emma and Yilmaz, Orhan and Zhu, Catherine Keying and Ghazal, Stephanie and Veilleux, Mylène and Bruns, Alessandra and Bissonnette, Lyne and Jariwala, Mehul and Batthish, Michelle and Muntyanu, Anastasiya and Mereniuk, Alexandra and Proulx-Gauthier, Jean-Philippe and Dionne, Marie-Claude and Pinard, Joanie and Rumsey, Dax G and Osman, Mohamed and Liy-Wong, Carmen and Luca, Nadia and Chédeville, Gaëlle and Gregory, Allison and Dutz, Jan P and McCuaig, Catherine C and Piram, Maryam and Pehr, Kevin and Laxer, Ronald M and Pope, Elena and Sibbald, Cathryn and Netchiporouk, Elena and Canadian Morphea Registry (C-MORE) Investigators, Canadian Morphea Registry (C-MORE) Investigators},
title = {The Canadian Morphea Registry: Design, Baseline Characteristics, and Age-Related Differences in a National Multicenter Cohort},
journal = {Journal of Cutaneous Medicine and Surgery},
year = {2026},
doi = {10.1177/12034754261490572}
}
EUVIMED